Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.
Saved in:
| Title: | Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage. |
|---|---|
| Authors: | Azevedo RS; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Jabbour E; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Jain N; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Haddad FG; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kebriaei P; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Khouri I; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Shpall EJ; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Champlin R; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA., Karrar O; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Maroun M; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Senapati J; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kugler E; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Garris RS; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Ravandi F; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Kantarjian H; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA., Short NJ; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA. nshort@mdanderson.org. |
| Source: | Leukemia [Leukemia] 2026 Jul 16. Date of Electronic Publication: 2026 Jul 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42463941 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Azevedo+RS%22">Azevedo RS</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Jabbour+E%22">Jabbour E</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Jain+N%22">Jain N</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Haddad+FG%22">Haddad FG</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Kebriaei+P%22">Kebriaei P</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Khouri+I%22">Khouri I</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Shpall+EJ%22">Shpall EJ</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Champlin+R%22">Champlin R</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Karrar+O%22">Karrar O</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Maroun+M%22">Maroun M</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Senapati+J%22">Senapati J</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Kugler+E%22">Kugler E</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Garris+RS%22">Garris RS</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Kantarjian+H%22">Kantarjian H</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Short+NJ%22">Short NJ</searchLink>; The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, USA. nshort@mdanderson.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2026 Jul 16. <i>Date of Electronic Publication: </i>2026 Jul 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42463941 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-026-03056-4 Languages: – Code: eng Text: English Titles: – TitleFull: Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Azevedo RS – PersonEntity: Name: NameFull: Jabbour E – PersonEntity: Name: NameFull: Jain N – PersonEntity: Name: NameFull: Haddad FG – PersonEntity: Name: NameFull: Kebriaei P – PersonEntity: Name: NameFull: Khouri I – PersonEntity: Name: NameFull: Shpall EJ – PersonEntity: Name: NameFull: Champlin R – PersonEntity: Name: NameFull: Karrar O – PersonEntity: Name: NameFull: Maroun M – PersonEntity: Name: NameFull: Senapati J – PersonEntity: Name: NameFull: Kugler E – PersonEntity: Name: NameFull: Garris RS – PersonEntity: Name: NameFull: Ravandi F – PersonEntity: Name: NameFull: Kantarjian H – PersonEntity: Name: NameFull: Short NJ IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 07 Text: 2026 Jul 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5551 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |